ERBB3 and neoplasm: In the histopathological examination of tumor material, it was found that treatment with the affibody constructs and MM-121 cause the downregulation of HER3, together with inflammatory cell reactions in the periphery of treated tumors (but not in the center of tumor cell islands), indicating a limited penetration depth of the molecules.